Soon Chun Hyang University Hospital Cheonan
Cheonan, Chungcheonam-do, 330-721, South Korea
NCT Number: NCT02025764
The prophylactic APC right after colonic EMR doesn't mean the complete coagulation of visible vessel because of injection material.
The aim of this study was to evaluate the clinical feature of the visible vessels in ulcer base over time after prophylactic APC in colonic EMR.
Looking for future studies?
Notify MeAll sexes
Observational
Cheonan, Chungcheonam-do, 330-721, South Korea
The prophylactic Argon plasma coagulation (APC) of non-bleeding visible vessels seems not to have an additional advantage in the prevention of delayed post polypectomy bleeding in recently studies. However, immediate APC after endoscopic mucosal resection (EMR) may not mean the complete coagulation of exposed vessels because of injection material. The aim of this study was to evaluate the clinical feature of the exposed vessels in ulcer base over time after prophylactic APC in colonic EMR. Methods: This study was designed as a prospective study. Investigators excluded diminutive polyp, large polyp (> 2cm), long stalk pedunculated polyp, and clear ulcer base after EMR. Between August 2013 and May 2014, patients who were enrolled underwent prophylactic APC for non-bleeding visible vessels after colonic endoscopic mucosal resection. After checking the complete coagulation of visible vessels, the numbers of visible vessel group were counted by lap of time such as 1, 3, 5, and 7 min in ulcer base.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 months
Soonchunhyang University Hospital
Other
The Clinical Feature of the Exposed Vessels in Ulcer Base Over Time After Prophylactic Argon Plasma Coagulation in Colonic Endoscopic Mucosal Resection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05816473
Digestive System Diseases, Gastrointestinal Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT03499808
Amorphous, Eosinophilic, and Acellular Deposit, Amyloidosis
Anchorage, Alaska, United States
View Trial DetailsNCT02514304
Cardiovascular Diseases, Digestive System Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT06269302
Anticoagulants and Bleeding Disorders, Cardiovascular Diseases
Samsun, İlkadım, Turkey (Türkiye)
View Trial Details